Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry
Angéla Dajnoki(Semmelweis University), Olaf A. Bodamer(Broad Institute), X. Kate Zhang, Wuh‐Liang Hwu(MRC Epidemiology Unit), Joseph J. Orsini, Joan Keutzer, Víctor R. De Jesús(Centers for Disease Control and Prevention), Zoltán Lukács(Universität Hamburg), Adolf Mühl(Medical University of Vienna), György Fekete, Yin‐Hsiu Chien(National Taiwan University Hospital)
Cited by 51
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Biparental Inheritance of Mitochondrial DNA in Humans
|Proceedings of the National Academy of Sciences|2018|451
PSORS2 Is Due to Mutations in CARD14
|The American Journal of Human Genetics|2012|414